Publicaciones en colaboración con investigadores/as de Hospital Universitari de Bellvitge (14)

2022

  1. Prevalence of symptomatic axial osteoarthritis phenotypes in Spain and associated socio-demographic, anthropometric, and lifestyle variables

    Rheumatology International, Vol. 42, Núm. 6, pp. 1085-1096

2021

  1. Prevalence of symptomatic osteoarthritis in Spain: EPISER2016 study

    Reumatologia Clinica, Vol. 17, Núm. 8, pp. 461-470

2020

  1. Efficacy and safety of glucocorticoids in rheumatoid arthritis: Systematic literature review

    Reumatologia Clinica, Vol. 16, Núm. 3, pp. 222-228

  2. Fracture risk assessment in the general population in Spain by FRAX® algorithm. EPISER2016 study

    Medicina Clinica, Vol. 154, Núm. 5, pp. 163-170

2019

  1. Prevalence of rheumatic diseases in adult population in Spain (EPISER 2016 study): Aims and methodology

    Reumatologia Clinica, Vol. 15, Núm. 2, pp. 90-96

2018

  1. Improvement in Diagnosis and Treat-to-Target Management of Hyperuricemia in Gout: Results from the GEMA-2 Transversal Study on Practice

    Rheumatology and Therapy, Vol. 5, Núm. 1, pp. 243-253

2015

  1. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990-2013: A systematic analysis for the Global Burden of Disease Study 2013

    The Lancet, Vol. 386, Núm. 10010, pp. 2287-2323

2014

  1. The burden of disease in Spain: Results from the global burden of disease study 2010

    BMC Medicine, Vol. 12, Núm. 1

2013

  1. Leflunomide, a valid and safe drug for the treatment of chronic anterior uveitis associated with juvenile idiopathic arthritis

    Clinical Rheumatology, Vol. 32, Núm. 11, pp. 1673-1675

2006

  1. Using serum urate levels to determine the period free of gouty symptoms after withdrawal of long-term urate-lowering therapy: A prospective study

    Arthritis Care and Research, Vol. 55, Núm. 5, pp. 786-790

2005

  1. Correction of allopurinol dosing should be based on clearance of creatinine, but not plasma creatinine levels: Another insight to allopurinol-related toxicity

    Journal of Clinical Rheumatology, Vol. 11, Núm. 3, pp. 129-133

2004

  1. Chronic infantile neurological cutaneous and articular syndrome: A new case with pseudotumor cerebri

    Neuro-Ophthalmology, Vol. 28, Núm. 4, pp. 187-190

2003

  1. Influence of leflunomide on renal handling of urate and phosphate in patients with rheumatoid arthritis

    Journal of Clinical Rheumatology, Vol. 9, Núm. 4, pp. 215-218

  2. Long-tern efficacy of hyperuricaemia treatment in renal transplant patients

    Nephrology Dialysis Transplantation, Vol. 18, Núm. 3, pp. 603-606